LD
AGN.PRA

Lipe & Dalton’s Allergan plc AGN.PRA Stock Holding History

Lipe & Dalton’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,882
Closed -$1.63M – 90
2017
Q2 		$1.63M Buy
1,882
+120
+7% +$101K 1.05% 35
2017
Q1 		$1.49M Buy
1,762
+645
+58% +$534K 1.08% 34
2016
Q4 		$850K Buy
1,117
+265
+31% +$200K 0.6% 39
2016
Q3 		$700K Buy
852
+512
+151% +$443K 0.47% 46
2016
Q2 		$283K Buy
+340
New +$284K 0.2% 65

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Lipe & Dalton's AGN.PRA Position: Q3 2017 in Review

Lipe & Dalton sold out of Allergan plc (AGN.PRA) in Q3 2017, closing a stake of 1,882 shares — an estimated $1.63M sold.

Lipe & Dalton first reported a position in AGN.PRA in Q2 2016 and held it in 5 quarters. The position peaked at $1.63M in Q2 2017. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2017.

  • Lipe & Dalton reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Lipe & Dalton sold 1,882 Allergan plc shares in Q3 2017, an estimated $1.63M.
  • Lipe & Dalton first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • Lipe & Dalton's Allergan plc position peaked at $1.63M in Q2 2017.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Lipe & Dalton's 13F filing for Q3 2017, filed 3 Nov 2017.